BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12538469)

  • 1. Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
    Ferrandina G; Pierelli L; Perillo A; Rutella S; Ludovisi M; Leone G; Mancuso S; Scambia G
    Clin Cancer Res; 2003 Jan; 9(1):195-200. PubMed ID: 12538469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.
    Kim DH; Sohn SK; Won DI; Lee NY; Suh JS; Lee KB
    Bone Marrow Transplant; 2006 Jun; 37(12):1119-28. PubMed ID: 16699530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
    Koehl U; Bochennek K; Zimmermann SY; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner HP; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T
    Bone Marrow Transplant; 2007 Mar; 39(5):269-78. PubMed ID: 17311085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
    Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
    Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
    Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
    Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of hematological and immunological function during long-term follow-up after peripheral blood stem cell transplantation.
    Laurenti L; Sica S; Salutari P; Rutella S; Serafini R; D'Onofrio G; Rumi C; Leone G
    Haematologica; 1998 Feb; 83(2):138-42. PubMed ID: 9549925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of CD4+ T-lymphocytes in children exposed to environmental lead.
    Li S; Zhengyan Z; Rong L; Hanyun C
    Biol Trace Elem Res; 2005; 105(1-3):19-25. PubMed ID: 16034150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
    Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
    Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR; Mayani H
    Ann Hematol; 2006 Feb; 85(2):113-20. PubMed ID: 16311734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
    Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
    Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3 bright lymphocyte population reveal gammadelta T cells.
    Lambert C; Genin C
    Cytometry B Clin Cytom; 2004 Sep; 61(1):45-53. PubMed ID: 15351982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.